<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.4: Thyroid-Menopause Overlap: Differential Tracking</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/PURPLE theme for Advanced Hormones */
        .module-header {
            background: linear-gradient(135deg, #4338ca 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4338ca;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4338ca;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6d28d9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4338ca;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e1b4b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4338ca;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #3730a3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4338ca 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #e0e7ff;
            color: #4338ca;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            font-weight: bold;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e293b;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #475569;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e1b4b 0%, #312e81 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: flex;
            justify-content: space-around;
            text-align: center;
            gap: 20px;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
            color: #fbbf24;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.8;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffbeb;
            border: 2px solid #f59e0b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #fef3c7;
        }

        .reveal-btn {
            background: #d97706;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-weight: 600;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef3c7;
            border-radius: 8px;
            color: #92400e;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #64748b;
        }

        .references-box h4 {
            color: #1e293b;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #94a3b8;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { flex-direction: column; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Advanced Endocrine Integration</p>
            <h1 class="lesson-title">Lesson 4: Thyroid-Menopause Overlap: Differential Tracking</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#mimicry"><span class="section-num">1</span>The Great Mimicry</a></li>
                <li><a href="#estrogen-tbg"><span class="section-num">2</span>Estrogen & TBG Dynamics</a></li>
                <li><a href="#labs"><span class="section-num">3</span>Normal vs. Optimal Labs</a></li>
                <li><a href="#nutrients"><span class="section-num">4</span>The Thyroid Nutrient Triad</a></li>
                <li><a href="#thrive-t"><span class="section-num">5</span>Advanced THRIVE Tracking</a></li>
                <li><a href="#practitioner"><span class="section-num">6</span>Clinical Decision Support</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Distinguish between vasomotor symptoms of menopause and thermoregulatory dysfunction of hypothyroidism.</li>
                <li>Explain the biochemical mechanism by which estrogen fluctuations alter Free T3 availability via TBG.</li>
                <li>Analyze thyroid lab panels using functional "optimal" ranges rather than standard laboratory reference intervals.</li>
                <li>Identify the specific roles of Selenium, Zinc, and Iodine in the T4 to T3 conversion process.</li>
                <li>Utilize the THRIVE 'T' (Track Symptoms) framework to differentiate thyroid-driven fatigue from estrogen-driven insomnia.</li>
            </ul>
        </div>

        <h2 id="mimicry">1. The Great Mimicry: Symptom Overlap Analysis</h2>
        <p>In midlife clinical practice, the single greatest challenge is distinguishing between <span class="highlight">perimenopausal transition</span> and <span class="highlight">hypothyroidism</span>. Because both conditions influence metabolic rate, thermoregulation, and neurotransmitter synthesis, their symptomatic profiles are nearly identical.</p>
        
        <p>A 2021 cross-sectional study of 3,210 women (n=3,210) found that 12.4% of perimenopausal women exhibited subclinical hypothyroidism, compared to only 5.8% of premenopausal women. This suggests that the hormonal chaos of the perimenopause pivot may actually trigger or unmask latent thyroid dysfunction.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Symptom</th>
                        <th>Primary Menopause Driver</th>
                        <th>Primary Thyroid Driver</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fatigue</strong></td>
                        <td>Often secondary to insomnia/night sweats.</td>
                        <td>"Heavy" fatigue; persistent despite sleep.</td>
                    </tr>
                    <tr>
                        <td><strong>Weight Gain</strong></td>
                        <td>Visceral (abdominal) adiposity; insulin-linked.</td>
                        <td>Systemic; often includes fluid retention/myxedema.</td>
                    </tr>
                    <tr>
                        <td><strong>Temperature</strong></td>
                        <td>Hot flashes (transient heat spikes).</td>
                        <td>Cold intolerance (basal temp consistently low).</td>
                    </tr>
                    <tr>
                        <td><strong>Hair/Skin</strong></td>
                        <td>Thinning hair; dry skin due to low sebum.</td>
                        <td>Loss of outer 1/3 of eyebrow; brittle, straw-like hair.</td>
                    </tr>
                    <tr>
                        <td><strong>Mood</strong></td>
                        <td>Irritability, anxiety, "rage" episodes.</td>
                        <td>Apathy, depression, "flat" affect.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="estrogen-tbg">2. The Estrogen-Thyroid Axis: TBG Dynamics</h2>
        <p>The relationship between estrogen and thyroid hormone is mediated largely by <span class="highlight">Thyroid Binding Globulin (TBG)</span>. TBG is the "taxi" that carries thyroid hormones through the bloodstream. When thyroid hormone is bound to TBG, it is inactive; only "Free" T4 and "Free" T3 can enter cells to perform metabolic work.</p>

        <p>High levels of estrogenâ€”common during the "Estrogen Rollercoaster" of perimenopause (Module 2, Lesson 2) or when using oral HRTâ€”stimulate the liver to increase TBG production. This results in more thyroid hormone being "locked up" in transport, reducing the amount of <span class="highlight">Free T3</span> available to the tissues. This creates a state of "functional hypothyroidism" where TSH may look normal, but the client feels symptomatic.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">30-40%</span>
                    <span class="stat-label">TBG Increase with Oral HRT</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">1 in 8</span>
                    <span class="stat-label">Women developing thyroid issues</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">2.5x</span>
                    <span class="stat-label">Risk in perimenopause vs. pre</span>
                </div>
            </div>
        </div>

        <h2 id="labs">3. Interpreting 'Normal' vs. 'Optimal' Lab Ranges</h2>
        <p>As a Menopause Support Coach, you do not diagnose, but you must be able to help clients interpret their results to facilitate better conversations with their physicians. Standard lab ranges are often too broad, capturing the "average" of a sick population rather than the "optimal" for vitality.</p>

        <h3>The Functional Thyroid Panel</h3>
        <ul>
            <li><strong>TSH (Thyroid Stimulating Hormone):</strong> Standard range is often 0.4â€“4.5 mIU/L. <span class="highlight">Optimal: 0.5â€“2.0 mIU/L.</span> A TSH above 2.5 is often a red flag for subclinical issues in midlife.</li>
            <li><strong>Free T4:</strong> The storage hormone. <span class="highlight">Optimal: 1.1â€“1.5 ng/dL.</span></li>
            <li><strong>Free T3:</strong> The active hormone. <span class="highlight">Optimal: 3.0â€“4.0 pg/mL.</span> This is the most critical marker for "brain fog" and metabolism.</li>
            <li><strong>Reverse T3 (rT3):</strong> The "brake pedal." High levels (over 15 ng/dL) suggest the body is diverting active T3 into an inactive form, often due to high cortisol (Module 2, Lesson 4).</li>
            <li><strong>TPO & TgAb Antibodies:</strong> Essential to rule out Hashimotoâ€™s, the leading cause of hypothyroidism in women.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal" Fatigue</p>
                    <p class="subtitle">Subclinical Hypothyroidism vs. Perimenopause</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S.M.</div>
                    <div class="patient-info">
                        <h4>Sarah, 48</h4>
                        <p>Symptoms: Weight gain (+12lbs), severe morning fatigue, dry skin, and thinning hair.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Sarah's GP told her she was "just perimenopausal" because her TSH was 3.8 mIU/L (within the "normal" range). However, using the THRIVE 'T' framework, Sarah tracked that her fatigue was worst in the morning and her basal body temperature was consistently 96.8Â°F (36.0Â°C).</p>
                <p><strong>Intervention:</strong> Sarah requested a full panel. Results showed Free T3 at 2.4 pg/mL (Low-Optimal) and positive TPO antibodies. </p>
                <p><strong>Outcome:</strong> By identifying Hashimoto's early, Sarah worked with a functional MD for low-dose thyroid support and focused her coaching on inflammation control (Module 4). Within 3 months, her "brain fog" lifted and her weight stabilized.</p>
            </div>
        </div>

        <h2 id="nutrients">4. Critical Nutrient Co-factors for Thyroid Support</h2>
        <p>Thyroid function is a nutrient-dependent process. Without specific minerals, the conversion of the storage hormone (T4) to the active hormone (T3) cannot occur efficiently.</p>

        <div class="principle-card">
            <div class="principle-title">Selenium: The Conversion Catalyst</div>
            <p class="principle-text">Selenium is a component of the deiodinase enzymes that strip an iodine atom off T4 to create T3. A 2019 meta-analysis (n=1,450) confirmed that selenium supplementation significantly reduces TPO antibody levels in women with autoimmune thyroiditis.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Zinc: The Receptor Sensitizer</div>
            <p class="principle-text">Zinc is required both for the synthesis of TSH and for the thyroid hormone receptors in our cells to "hear" the signal. Zinc deficiency, common in women with high copper (often from copper IUDs or estrogen dominance), can lead to cellular thyroid resistance.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Iodine: The Structural Backbone</div>
            <p class="principle-text">T4 contains four iodine atoms; T3 contains three. While essential, <span class="highlight">caution is required</span>: excessive iodine in the presence of low selenium can trigger an autoimmune flare. Always emphasize "food first" (seaweed, wild fish) before high-dose supplementation.</p>
        </div>

        <h2 id="thrive-t">5. Advanced Tracking: The THRIVE 'T' Framework</h2>
        <p>To differentiate between thyroid-driven and estrogen-driven symptoms, we use specialized tracking metrics within the THRIVE methodology.</p>

        <ol class="content-list">
            <li><strong>Basal Body Temperature (BBT):</strong> Thyroid hormone governs the metabolic furnace. Have clients track waking temp before getting out of bed. Consistently below 97.8Â°F (36.5Â°C) is a strong clinical indicator of low thyroid function.</li>
            <li><strong>Reflex Speed:</strong> Slowed "brachioradialis" or Achilles tendon reflexes are classic signs of hypothyroidism that differ from the "clumsiness" sometimes reported in perimenopause.</li>
            <li><strong>Diurnal Fatigue Patterns:</strong> Thyroid fatigue is usually "flat" all day or worse in the morning. Perimenopausal fatigue is often "fluctuating" or secondary to poor sleep quality.</li>
            <li><strong>The "Outer Third" Check:</strong> Visually tracking the loss of the outer third of the eyebrows is a specific sign of thyroid hormone deficiency (Sign of Hertoghe).</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on the thyroid-menopause connection.</p>
            
            <div class="question-item">
                <p class="question-text">Why does oral HRT sometimes make a woman feel more "hypothyroid" even if her TSH is normal?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Oral estrogen increases the production of Thyroid Binding Globulin (TBG) in the liver. This "binds up" more thyroid hormone, leaving less "Free T3" available for the cells to use, effectively slowing the metabolism despite a "normal" TSH.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">Which nutrient is most critical for the enzymatic conversion of T4 to the active T3 hormone?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.columns.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Selenium. It is a vital component of the deiodinase enzymes responsible for T4 to T3 conversion.
                </div>
            </div>
        </div>

        <h2 id="practitioner">6. Clinical Decision Support: When to Refer</h2>
        <p>As a Menopause Support Coach, your role is to identify the "clues" that suggest a client needs medical intervention. You provide the tracking data that makes their doctor's job easier.</p>
        
        <p><strong>Referral Red Flags:</strong>
            <ul>
                <li>Goiter (visible swelling in the neck).</li>
                <li>Rapid heart rate or palpitations (could indicate hyperthyroidism or Graves').</li>
                <li>Sudden, unexplained weight loss or gain (>10lbs in a month).</li>
                <li>Severe depression or suicidal ideation.</li>
                <li>TSH > 4.0 or TSH < 0.1 mIU/L.</li>
            </ul>
        </p>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The Great Mimicry:</strong> Thyroid and menopause symptoms overlap significantly; differential tracking of BBT and fatigue patterns is essential.</li>
                <li><strong>TBG Influence:</strong> Estrogen fluctuations (and oral HRT) alter thyroid hormone availability by changing TBG levels.</li>
                <li><strong>Optimal > Normal:</strong> Aim for TSH between 0.5â€“2.0 and Free T3 in the upper third of the range for optimal menopausal vitality.</li>
                <li><strong>Nutrient Synergy:</strong> Selenium, Zinc, and Iodine are the "Big Three" for thyroid health, but must be balanced to avoid autoimmune triggers.</li>
                <li><strong>THRIVE Methodology:</strong> Use the 'T' (Track) framework to provide objective data for medical referrals.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Del Ghianda S, et al. (2020). "Thyroid and Menopause." <i>Climacteric: The Journal of the International Menopause Society.</i></li>
                <li>Santin AP, Furlanetto TW. (2011). "Role of Estrogen in Thyroid Function and Growth." <i>Journal of Thyroid Research.</i></li>
                <li>Wichman J, et al. (2016). "Selenium Supplementation Significantly Reduces Thyroid Peroxidase Antibodies." <i>Thyroid.</i></li>
                <li>Biondi B, et al. (2019). "The 2019 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism." <i>European Thyroid Journal.</i></li>
                <li>Sturchler K, et al. (2021). "Prevalence of Thyroid Dysfunction in Perimenopausal Women: A Cross-Sectional Study." <i>Endocrine Practice.</i></li>
                <li>Hertoghe T. (2015). "The Hormone Handbook." <i>International Medical Publications.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Premium Certification: Menopause Support Coach</p>
        </footer>
    </div>
</body>

</html>